Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

Researchers have suspected for some time that the link between our gut and brain plays a role in the development of Parkinson ...

SPR301 is a potential best-in-class gene therapy candidate that delivers a more stable, rationally engineered version of GCase, the enzyme ...

Nearly one million people in the U.S. are living with Parkinson’s disease (PD), and this number is expected to grow to 1.2 ...

Mill Race Center is offering Parkinson’s disease support groups beginning this month.

Shares of Serina Therapeutics, Inc. surged over 15% in pre-market trading on Tuesday, positioning the clinical-stage biotech ...

A survey of experts in aging research reveals significant disagreements on fundamental questions, such as "What is aging?" ...

Robert Joseph “RJ” Weber, 70, passed away peacefully on Dec. 1, 2024, after his battle with Parkinson’s disease. He was born ...

ABC News welcomes the ABC Ombudsman’s findings regarding "After the Harvest", a series of reports regarding concerns held by ...

Despite a rough year, with a -65.45% YTD decline, Serina’s recent financing deal and innovative pipeline suggest that the company is poised for a comeback. Investors will be closely watching the ...

Dada, Further Enhances Board Expertise. NEW YORK, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Klotho Neurosciences, Inc. (NASDAQ: KLTO), a ...

Serina Therapeutics shares were up 24% to $5.88 in premarket trading after the company said it secured $10 million in equity financing from strategic shareholder JuvVentures (UK) Limited.